Barry Shin
Equibles does not estimate personal net worth.
Get an email with a short summary when Compass Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CMPX alertsAbout Barry Shin
Barry Shin is recorded as CFO at Compass Therapeutics, Inc. (CMPX) since December 9, 2024. The newest filing on record that lists Barry Shin as CFO at Compass Therapeutics, Inc. (CMPX) is dated April 29, 2026. Compass Therapeutics, Inc. reported in an 8-K filed December 10, 2024 that Barry Shin was appointed Chief Financial Officer, effective December 9, 2024. The proxy statement of Compass Therapeutics, Inc. reports total compensation of $1,394,500 for Barry Shin in fiscal 2025, including a base salary of $480,000. Disclosed compensation is on record for 3 fiscal years. Compass Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Compass Therapeutics, Inc. includes Thomas J. Schuetz (CEO and Board Member), Thomas Schuetz (CEO and Board Member), Thomas Schuetz, MD, PhD (CEO and Chairman) and 7 others.
“On December 10, 2024, Compass Therapeutics, Inc. (the “Company”) announced the decision of the Company’s Board of Directors (the “Board”) to appoint Barry Shin, J.D., M.B.A. age 53, as the Company’s Chief Financial Officer (“CFO”) and principal financial officer effective December 9, 2024.”
Affiliation history
-
Current
2024-12-09–present
Last confirmed April 29, 2026
Company network
Leadership on record at Compass Therapeutics, Inc.
- Thomas J. Schuetz CEO, Board Member
- Thomas Schuetz CEO, Board Member
- Thomas Schuetz, MD, PhD CEO, Chairman
- Vered Bisker-Leib, PhD CEO, Board Member
- Dr. Bisker-Leib COO
- Vered Bisker-Leib COO
- Jonathan E. Anderman General Counsel
- Neil Lerner Chief Accounting Officer
- Brett Kaplan, M.D. Board Member
- David Wurzer Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Compass Therapeutics, Inc. (CMPX) | Chief Financial Officer | $480,000 | $1,394,500 |
| 2024 | Compass Therapeutics, Inc. (CMPX) | Chief Financial Officer | $29,688 | $1,220,942 |
| 2023 | Compass Therapeutics, Inc. (CMPX) | Chief Financial Officer | — | — |